Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Guerbet Group

Guerbet Group
1926 FOUNDED
PUBLIC STATUS
901-1000 EMPLOYEES
GBT STOCK SYMBOL
5 INVESTMENTS
$30.89 SHARE PRICE (As of Tuesday Closing)
Description

Guerbet is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol. It derives the majority of its revenue from the sale of magnetic resonance imaging.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PAR
Primary Office
  • BP 57400
  • Roissy CdG Cedex
  • 95943 Paris
  • France

+33 01 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Guerbet Group’s full profile, request a free trial.

Guerbet Group Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$28.48 - $64.65 $388M $30.36 $3.94 9.8K 12.6M

Guerbet Group Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 977,349 1,063,782 1,452,669 1,195,325
Revenue 918,955 937,695 911,944 858,888
EBITDA 137,319 140,391 130,821 114,061
Net Income 49,548 55,250 52,124 32,001
Total Assets 1,214,797 1,236,340 1,144,027 1,081,310
Total Debt 493,351 475,197 424,446 418,987
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guerbet Group Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Navidea Biopharmaceuticals Corporation Dublin, OH 00 00000 000000000 00000
0000000 0000000000 Venture Capital-Backed Sydney, Australia 0 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

Guerbet Group Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00000000 26-Apr-2018 000000000 00000 00 00.000 Buildings and Property
00000000 0000000 0 01-Jan-2018 000000000000000000 000.00 Surgical Devices 0000 0'00000
000000000000 (0000 27-Nov-2015 000000000000000000 00000 Diagnostic Equipment 0000 0'00000
00000 0000000000 01-Jan-2010 000000000 Medical Supplies
Medex Biomedical 01-Jun-2004 Merger/Acquisition 00.000 Medical Supplies
To view this company’s complete investment and acquisition history, request access »

Guerbet Group Subsidiaries (1)

Company Name Industry Location Founded
00000 0000000000 Medical Supplies Saint Priest, France 0000
To view this company’s complete subsidiary history, request access »

Guerbet Group Executive Team (5)

Name Title Board
Seat
Contact
Info
Yves L'Epine Chief Executive Officer
Jean-François Le Martret Deputy Chief Executive Officer
Jérôme Estampes Chief Financial Officer
David Hale Chief Commercial Officer, Diagnostic Imaging
Jean-François Blanc Vice President, Technical Operations